These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15322734)

  • 21. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein.
    Lecoeur S; Videmann B; Mazallon M
    Toxicol Lett; 2006 Mar; 161(3):200-9. PubMed ID: 16221533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.
    Joseph B; Bhargava KK; Malhi H; Schilsky ML; Jain D; Palestro CJ; Gupta S
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1024-31. PubMed ID: 12536246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
    Katoh M; Suzuyama N; Takeuchi T; Yoshitomi S; Asahi S; Yokoi T
    J Pharm Sci; 2006 Dec; 95(12):2673-83. PubMed ID: 16892207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.
    Booth-Genthe CL; Louie SW; Carlini EJ; Li B; Leake BF; Eisenhandler R; Hochman JH; Mei Q; Kim RB; Rushmore TH; Yamazaki M
    J Pharmacol Toxicol Methods; 2006; 54(1):78-89. PubMed ID: 16545584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments].
    Fromm MF; Kim RB; Stein CM; Wilkinson GR; Roden DM
    Circulation; 1999 Feb; 99(4):552-7. PubMed ID: 9927403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.
    Jonker JW; Wagenaar E; van Deemter L; Gottschlich R; Bender HM; Dasenbrock J; Schinkel AH
    Br J Pharmacol; 1999 May; 127(1):43-50. PubMed ID: 10369454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice.
    Xie R; Hammarlund-Udenaes M; de Boer AG; de Lange EC
    Br J Pharmacol; 1999 Oct; 128(3):563-8. PubMed ID: 10516633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption.
    Uhr M; Steckler T; Yassouridis A; Holsboer F
    Neuropsychopharmacology; 2000 Apr; 22(4):380-7. PubMed ID: 10700657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
    Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.
    Fuchs H; Kishimoto W; Gansser D; Tanswell P; Ishiguro N
    Drug Metab Dispos; 2014 Oct; 42(10):1761-5. PubMed ID: 25053619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of axitinib interactions with human efflux and hepatic uptake transporters: implications for disposition and drug interactions.
    Reyner EL; Sevidal S; West MA; Clouser-Roche A; Freiwald S; Fenner K; Ullah M; Lee CA; Smith BJ
    Drug Metab Dispos; 2013 Aug; 41(8):1575-83. PubMed ID: 23729661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
    Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
    J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anthelminthic agent albendazole does not interact with p-glycoprotein.
    Merino G; Alvarez AI; Prieto JG; Kim RB
    Drug Metab Dispos; 2002 Apr; 30(4):365-9. PubMed ID: 11901088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased uptake of quinine into the brain by inhibition of P-glycoprotein.
    Pussard E; Merzouk M; Barennes H
    Eur J Pharm Sci; 2007 Oct; 32(2):123-7. PubMed ID: 17698330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein.
    Morimoto K; Nakakariya M; Shirasaka Y; Kakinuma C; Fujita T; Tamai I; Ogihara T
    Drug Metab Dispos; 2008 Jan; 36(1):6-9. PubMed ID: 17940134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
    Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
    Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.